Om du vill rapportera en biverkning gällande en av Lillys produkter, kontakta oss via e-post på DK_PHv@lilly.com eller på telefon +45 4526 6040. Har du ytterligare medicinska frågor gällande en av Lillys produkter, kontakta oss via länken ovan.
Baqsimi ® (glukagon näspulver)
Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska
Pregnancy
NG can be used during pregnancy. Glucagon does not cross the human placental barrier. The use of glucagon has been reported in pregnant women with diabetes and no harmful effects are known with respect to the course of pregnancy and the health of the unborn and the neonate.1
Lactation
NG can be used during breast-feeding. Glucagon is cleared from the bloodstream very quickly and thus the amount excreted in the milk of nursing mothers following treatment of severe hypoglycaemic reactions is expected to be extremely small. As glucagon is degraded in the digestive tract and cannot be absorbed in its intact form, it will not exert any metabolic effect in the child. 1
1. Baqsimi [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
Glossary
GI = gastrointestinal
NG = nasal glucagon (glucagon nasal powder)
Datum fӧr senaste ӧversyn 2019 M07 24